Comparison of reporting rates of arthritis and arthralgia following AstraZeneca, Pfizer-BioNTech, Moderna, and Janssen vaccine administration against SARS-CoV-2 in 2021: analysis of European pharmacovigilance large-scale data.

This study aimed to investigate the reporting rates of arthritis and arthralgia following the administration of four vaccines against SARS-CoV-2: Pfizer-BioNTech (Tozinameran), Moderna (CX-024414), AstraZeneca (Chadox1 NCOV-19), and Janssen (AD26.COV2.S) in 2021. We used data from the EudraVigilance database, specifically analyzing spontaneous reports of suspected adverse reactions (ADRs) from the European Union (EU)/European Economic Area (EEA) region. Age-group-specific reporting rates were calculated by dividing the number of arthralgia and arthritis reports per 1,000,000 vaccine doses administered per age group. Reporting rates were compared using a rate ratio among the four vaccines, using the AstraZeneca vaccine as a comparator. The AstraZeneca vaccine was associated with the highest rate of arthralgia across all age groups. Arthritis reporting rates were significantly lower, with the AstraZeneca vaccine having the highest rates in most age groups, except the 60-69 and 80+ groups, where the Janssen and Pfizer-BioNTech vaccines demonstrated higher reporting rates, respectively. The distribution of arthritis rates did not follow the arthralgia pattern, being higher in the 50-79 age group. This study is the first spontaneous reporting system analysis of arthritis reporting rates post-SARS-CoV-2 vaccination at a European level, revealing a higher reporting of suspected musculoskeletal adverse reactions after AstraZeneca vaccination. The findings underscore the need to consider commonly reported events like arthralgia in risk-benefit assessments prior to vaccination against SARS-CoV-2. Given the high prevalence of rheumatic and musculoskeletal diseases and vaccine hesitancy in this population, our results could influence vaccine choice and acceptance.

Atypical Peripheral Ossifying Fibroma of the Mandible.

Peripheral ossifying fibroma (POF) is a benign localized lesion originating from gingival and alveolar oral mucosa. Its origin can be cells of periodontal ligament. The lesions usually develop in women in their twenties. POF is a complex clinical and histological diagnosis due to its shared characteristics with many other conditions. In this paper, we presented a case of an atypical peripheral ossifying fibroma (POF) in the left lateral part of the mandible in a 70-year-old male patient who had two semicircular bridges supported on four implants in the upper and lower jaws. A review of CBCT and orthopedic imaging showed no visible intraosseous changes. Histological analysis revealed the diagnosis of POF. The case in question is interesting, as elaborated on in the discussion section of this paper because POF is usually found in female patients aged between 20 and 30 years.

Symmetrical Fibrous Hyperplasia of the Palate.

Bilateral symmetrical fibrous palate hyperplasia is not a common case in the literature. The cause of this pathological change is not completely known. The development of hyperplasia may also be associated with a genetic mutation in the gingival soft tissue or gingival injury. We present a case of a 47-year-old patient who developed a formation that manifested bilaterally in the hard palate. After the excision, there were no histological elements in the material that indicated aggressive behavior of the formation. The clinical and histological diagnosis was the bilateral symmetrical palate hyperplasia, which is a very rare condition.

Incidence of Dentinal Microcracks during Root Canal Preparation with Self Adjusting File, Reciproc Blue and ProTaper Next.

Introduction: Forces formed during root canal instrumentation could cause the crack formation in dentinal walls. Their propagation may result in vertical root fracture and eventually tooth loss. The aim of the study was to explore microcrack formation after root canal preparation with Self-adjusting File (SAF), Reciproc Blue (RB), and ProTaper Next (PTN) instruments on young premolars by means of micro-computed tomography (micro CT). Methods and Materials: Forty-five upper premolars with two canals, were extracted due to orthodontic reasons from patients aged 16 to 20 years and stored for up to two months. The teeth were scanned with a micro-CT (Nikon XT H 225, Tring, UK) at structural resolution of 20.2 µm and randomly divided into three groups: SAF, RB, and PTN. Specimens were instrumented and irrigation was performed with 12 mL of 2.5% sodium hypochlorite (NaOCl) and 4 mL of 17% ethylenediaminetetraacetic acid (EDTA) per root canal. Subsequently, the specimens were scanned under the same conditions as before, in wet condition and 24 h after drying. The presence of microcracks in dentinal walls was evaluated using the image-processing software Volume Graphics VGStudio Max 3. Results: No dentinal defect was found in any evaluated specimen, neither in pre-nor post-operative scans in wet and dry condition. Conclusion: Under the circumstances of this in vitro study instruments with improved design and metallurgy do not cause dentinal microcracks in young premolar teeth.